PSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
From the NYTimes: The psychedelic revolution Is coming, and psychiatry may never be the same.
Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. Some worry a push to loosen access could bring unintended consequences.
Read moreHere’s a timeline through psychedelic events in human history, from over 7000 years ago.
Read moreAs we imagine a future with positive cultural norms around psychedelics, the book “Animals and Psychedelics: The Natural World and the Instinct to Alter Consciousness” by Italian ethnobotanist and ethnomycologist Giorgio Samorini may offer us some guidance.
Read moreGreat news! The first Phase 3 trial of MDMA-assisted therapy for posttraumatic stress disorder (PTSD) replicated and expanded on Phase 2 results indicating MDMA-assisted therapy may be an effective and cost-saving treatment for PTSD resulting from any cause.
Read more‘Mother Trees’ are intelligent, they learn and remember. And ecologist Suzanne Simard says they need our help to survive.
Read moreNew research shows that benefits of microdosing may be comparable to other wellness activities such as yoga.
Read moreA growing list of athletes are looking to psychedelic substances for healing brain trauma.
Read moreAs psychedelic research moves ahead, 5-MeO-DMT is gaining recognition for its ability to treat a number of conditions.
Read morePsychedelic drugs without the trip?
This sensor could help seek them out. An easier way to identify non-hallucinogenic psychedelics could aid treatment for illnesses such as depression and PTSD.
Read moreThis study reports that psilocybin provides long-term relief of cancer-related anxiety and depression.
Read moreThe California chemist Sasha Shulgin is known as the ‘Godfather of MDMA,’ but his legacy lies in countless drugs that remain a mystery to scientists and psychonauts alike. Keep reading to learn more.
Read more